Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work

For the first time in the company's history, revenues earned on programs for pharma innovator companies surpassed generics programsInnovation revenue rose from 35% of total in FY19 to more than 50% in FY24CAGR of 20% for innovator work far exceeds the overall CDMO business's benchmark 

* Includes one facility via PPL's minority investment in Yapan Bio.

Photo: https://mma.prnewswire.com/media/2471732/Peter_DeYoung_Piramal.jpg
Logo: https://mma.prnewswire.com/media/1726186/4462420/Piramal_Pharma_Solutions_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-solutions-achieves-revenue-threshold-on-innovation-work-302209812.html